- Company Overview for TETRIS PHARMA LTD (12548259)
- Filing history for TETRIS PHARMA LTD (12548259)
- People for TETRIS PHARMA LTD (12548259)
- Charges for TETRIS PHARMA LTD (12548259)
- More for TETRIS PHARMA LTD (12548259)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
11 Sep 2024 | AA | Full accounts made up to 31 December 2023 | |
18 Jul 2024 | AP01 | Appointment of Dr Jan Jezek as a director on 17 July 2024 | |
18 Jul 2024 | TM01 | Termination of appointment of Susan Day Lowther as a director on 17 July 2024 | |
29 Apr 2024 | CS01 | Confirmation statement made on 29 April 2024 with updates | |
04 Oct 2023 | TM01 | Termination of appointment of Shafiq Mohammed Choudhary as a director on 22 September 2023 | |
17 Jul 2023 | AA | Full accounts made up to 31 December 2022 | |
23 May 2023 | CS01 | Confirmation statement made on 15 May 2023 with updates | |
15 Dec 2022 | MR04 | Satisfaction of charge 125482590001 in full | |
15 Nov 2022 | AA01 | Current accounting period shortened from 30 April 2023 to 31 December 2022 | |
01 Nov 2022 | AA | Total exemption full accounts made up to 30 April 2022 | |
01 Sep 2022 | SH01 |
Statement of capital following an allotment of shares on 31 July 2022
|
|
01 Sep 2022 | RESOLUTIONS |
Resolutions
|
|
22 Aug 2022 | MA | Memorandum and Articles of Association | |
18 Aug 2022 | AP01 | Appointment of Dr. Sarah Jennifer Howell as a director on 4 August 2022 | |
11 Aug 2022 | PSC02 | Notification of Arecor Therapeutics Plc as a person with significant control on 4 August 2022 | |
11 Aug 2022 | PSC09 | Withdrawal of a person with significant control statement on 11 August 2022 | |
10 Aug 2022 | AP01 | Appointment of Susan Day Lowther as a director on 4 August 2022 | |
10 Aug 2022 | TM01 | Termination of appointment of Madeleine Elizabeth Kennedy as a director on 4 August 2022 | |
10 Aug 2022 | TM01 | Termination of appointment of John Leslie Galloway as a director on 4 August 2022 | |
09 Aug 2022 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 25 July 2022
|
|
27 Jul 2022 | SH01 |
Statement of capital following an allotment of shares on 21 July 2022
|
|
27 Jul 2022 | RESOLUTIONS |
Resolutions
|
|
18 Jul 2022 | SH19 |
Statement of capital on 18 July 2022
|
|
18 Jul 2022 | OC138 | Reduction of iss capital and minute (oc) | |
18 Jul 2022 | CERT16 | Certificate of reduction of issued capital and share premium |